Related Experiment Video
Updated: Nov 8, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.9K
How community pharmacists envision using pharmacogenomic data: A qualitative analysis.
Journal of the American Pharmacists Association : Japha
|April 24, 2021
Summary
Community pharmacists are ready to integrate pharmacogenomic data into their workflow. They envision using dispensing software alerts and clinical guidelines to personalize medication therapy and improve patient counseling.
Area of Science:
- Pharmacogenomics
- Pharmacy Practice
- Clinical Decision Support
Background:
- Nearly 300 medications have pharmacogenomic information in U.S. FDA labeling.
- The number of pharmacogenomic drugs is increasing.
- Community pharmacists will increasingly use pharmacogenomic data at dispensing.
Purpose of the Study:
- To describe how pharmacists envision integrating pharmacogenomic data into community pharmacy workflows.
- To identify key elements for successful pharmacogenomic data integration.
Main Methods:
- Qualitative study using semistructured interviews with community pharmacists.
- Pharmacists were presented with clinical scenarios to gauge workflow integration.
- Thematic analysis of interview transcripts identified key themes.
Main Results:
- Pharmacists desire integration into dispensing software with alerts for actionable changes.
- Access to clinical guidelines for decision-making is crucial.
- Pharmacists prefer engaging prescribers and counseling patients at pick-up.
Conclusions:
- Pharmacists envision a workflow that includes software integration, alerts, and decision support.
- Engaging prescribers and patient counseling are key components.
- These findings are vital for implementing pharmacogenomic data in community pharmacies.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
522
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
522
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
43
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
43
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
169
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
169
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
301
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
301
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
324
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
324
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
155
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
155